M
Mark W. Tibbitt
Researcher at ETH Zurich
Publications - 88
Citations - 8018
Mark W. Tibbitt is an academic researcher from ETH Zurich. The author has contributed to research in topics: Self-healing hydrogels & Medicine. The author has an hindex of 31, co-authored 74 publications receiving 6232 citations. Previous affiliations of Mark W. Tibbitt include Howard Hughes Medical Institute & University of Zurich.
Papers
More filters
Journal ArticleDOI
Light activated cell migration in synthetic extracellular matrices.
Qiongyu Guo,Xiaobo Wang,Mark W. Tibbitt,Kristi S. Anseth,Denise J. Montell,Jennifer H. Elisseeff +5 more
TL;DR: This work presents a strategy for manipulating individual mammalian stem cells in defined synthetic hydrogels through selective optical activation of Rac, which is an intracellular signaling protein that plays a key role in cell migration.
Journal ArticleDOI
Thermal Stabilization of Biologics with Photoresponsive Hydrogels
Balaji V. Sridhar,Janczy John R,Oyvind Hatlevik,Gabriel Wolfson,Kristi S. Anseth,Mark W. Tibbitt +5 more
TL;DR: Hydrogel encapsulation improved stability for encapsulated enzymes commonly used in molecular biology (β-galactosidase, alkaline phosphatase, and T4 DNA ligase) following thermal stress, demonstrating a general method to employ reversible polymer networks as robust excipients for thermal stability of complex biologics during storage and shipment that additionally enable on-demand release of active molecules at the point of use.
Journal ArticleDOI
Human Retinal Microvasculature-on-a-Chip for Drug Discovery
Héloïse Ragelle,Karen Dernick,Sonia Khemais,Cordula Keppler,Lucien Cousin,Yohan Farouz,Chris Louche,Sascha Fauser,Stefan Kustermann,Mark W. Tibbitt,Peter D. Westenskow +10 more
TL;DR: A tunable organ‐on‐a‐chip model of the retinal microvasculature using human retinalmicrovascular endothelial cells with integrated flow will enable improved understanding of BRB biology and provide an additional tool for drug discovery.
Journal ArticleDOI
Immunofunctional photodegradable poly(ethylene glycol) hydrogel surfaces for the capture and release of rare cells
Paige J. LeValley,Mark W. Tibbitt,Ben Noren,Prathamesh M. Kharkar,April M. Kloxin,Kristi S. Anseth,Mehmet Toner,John Oakey +7 more
TL;DR: A patterned, immunofunctional, photodegradable PEG hydrogel capture surface is introduced for the isolation and selective release of rare cell populations and provides a micropatternable, cytocompatible platform that imparts the unique ability to recover pure, viable CTC samples by selectively releasing target cells.
Journal ArticleDOI
Long-term Normothermic Machine Preservation of Partial Livers: First Experience With 21 Human Hemi-livers.
Matteo Mueller,Max Hefti,Dilmurodjon Eshmuminov,Martin J. Schuler,Richard X Sousa Da Silva,Henrik Petrowsky,Michelle L. de Oliveira,Christian E. Oberkofler,Catherine Hagedorn,Leandro Mancina,Achim Weber,Brian Burg,Mark W. Tibbitt,Mark W. Tibbitt,Philipp Rudolf von Rohr,Philipp Rudolf von Rohr,Philipp Dutkowski,Dustin Becker,Lucia Bautista Borrego,Pierre-Alain Clavien +19 more
TL;DR: In this article, partial swine livers were perfused with autologous blood after being procured from healthy pigs following 70% in-vivo resection, leaving only the right lateral lobe.